Personalized Medicine Market Report 2026

Personalized Medicine Market Overview

• Personalized Medicine market size has reached to $422.9 billion in 2025 • Expected to grow to $733.27 billion in 2030 at a compound annual growth rate (CAGR) of 11.8% • Growth Driver: Impact Of Obesity On Personalized Medicine Growth • Market Trend: Technology Adoption By Major Companies In Personalized Medicine • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Medicine Market?

Personalized medicine is tailoring medical treatment to an individual's specific genetic, environmental, and lifestyle factors by considering an individual's unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time. The main products of personalized medicine are personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition and wellness. Personalized medicine diagnostics refers to studying an individual's specific genetic, molecular, and clinical characteristics to guide the diagnosis, treatment, and management of their disease. It is used in disease diagnosis, treatment selection, monitoring treatment response, and clinical trial selection. The various applications of personalized medicine include oncology, neurology, blood transfusion safety, diabetes, autoimmune diseases, cardiology, and others that are used in hospitals, diagnostic centers, research and academic institutes, and others.

What Is The Personalized Medicine Market Growth Forecast?

The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $733.27 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to integration of ai in diagnostics and therapeutics, expansion of gene and cell therapy products, growing demand for remote patient monitoring, development of precision nutrition solutions, increasing adoption of companion diagnostics. Major trends in the forecast period include personalized genetic profiling, targeted drug development, patient-centric care models, remote health monitoring, lifestyle-based preventive therapies.

Global Personalized Medicine Market Segmentation

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness 2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications 3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users Subsegments: 1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging 2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products 3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring 4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Is The Driver Of The Personalized Medicine Market?

The growing obese population is expected to propel the growth of the personalized medicine market going forward. Obesity refers to the abnormal or excessive accumulation of fat, which might impair the health of individuals. The personalized medicine is used in addressing the specific genetic and molecular factors contributing to obesity, thereby offering tailored and effective interventions for individuals. For instance, in December 2024, according to the Office for Health Improvement and Disparities, a UK-based government department From 2022 to 2023, the proportion of women recorded as living with obesity in early pregnancy was 25.4%, which increased slightly to 26.2% from 2023 to 2024. Therefore, the growing obese population is driving the growth of the personalized medicine industry.

Key Players In The Global Personalized Medicine Market

Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Global Personalized Medicine Market Trends and Insights

Major companies operating in the personalized medicine market are focusing on developing technological advancements such as artificial intelligence (AI)-powered platforms to enhance diagnosis accuracy, treatment personalization, and clinical trial efficiency. AI-powered platforms utilize large-scale data analysis to generate actionable insights into disease progression, patient response, and therapeutic outcomes. For instance, in April 2023, OM1, a US-based healthcare company leveraging real-world data and AI, patented an AI-powered platform to accelerate personalized medicine. The platform enables tailored healthcare recommendations, supports informed decision-making for healthcare providers, and expedites clinical trials by efficiently identifying suitable patient candidates. By integrating AI-driven analytics into healthcare workflows, the technology advances personalized medicine and strengthens market growth.

What Are Latest Mergers And Acquisitions In The Personalized Medicine Market?

In April 2023, 4D Molecular Therapeutics (4DMT), a US-based clinical-stage gene therapy company developing products to treat rare and prevalent diseases, acquired all world-wide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc. for $140 million. This acquisition signifies a significant advancement in personalized medicine for rare and genetic diseases, especially in treating geographic atrophy, by targeting the complement pathway and offering potential improvements in patient outcomes. Aevitas Therapeutics, Inc., is a US-based biopharmaceutical company focused on developing and commercializing gene therapies for complement-mediated diseases.

Regional Insights

North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Medicine Market?

The personalized medicine market consists of sales of topical creams, serums, dietary supplements, customized meal plans, nutritional products, and drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Personalized Medicine Market Report 2026?

The personalized medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.